Clinical Trial Update: JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure [Phase 1, Phase 2]

View source ↗

Summary

This document outlines a Phase 1/Phase 2 clinical trial evaluating JDB153 combined with Penpulimab for refractory hepatocellular carcinoma after standard treatm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• JDB153 (JDB153)
• Penpulimab

Snippet

Sponsor: West China Hospital | Conditions: Refractory Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING